Product Information
TWIRLA 120-30 MCG/DAY PATCH is a brand product labeled by Agile Therapeutics, Inc., priced at $66.9535 per EA under NDC 71671010003. Its NADAC has been published 250 times since Dec 22, 2021.
FDA first approved this application on Feb 14, 2020.
Strength
2.3; 2.6 mg/1; mg/1
Manufacturer
Agile Therapeutics, Inc.NDC
71671010003
Classification
Brand
Dosage Form
PATCH
Route
TRANSDERMAL
Effective Date
9/23/2026
Active Ingredients
ETHINYL ESTRADIOL; LEVONORGESTRELApproval Type
New Drug (NDA)
FDA Application
NDA204017FDA Approved
2/14/2020
On Market Since
9/11/2020
Pharmacological Classes
Price Statistics
The NADAC for TWIRLA 120-30 MCG/DAY PATCH has been published 250 times since Dec 22, 2021, and over the history we have for it it has risen 20.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $66.9535 per EA |
|---|---|
| All-time high | $67.2133 (May 13, 2026) |
| All-time low | $55.4013 (Dec 22, 2021) |
| 52-week high | $67.2133 |
| 52-week low | $65.2555 |
| Median price | $65.2555 |
| Average price | $63.4084 |
| Largest weekly change | +9.4% (Jul 20, 2022) |
| Weeks tracked | 250 |
| Tracking since | Dec 22, 2021 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the levonorgestrel/ethinyl estradiol market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Agile Therapeutics, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
levonorgestrel/ethinyl estradiol market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Estrogen class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TWIRLA 120-30 MCG/DAY PATCH?
The current National Average Drug Acquisition Cost (NADAC) for TWIRLA 120-30 MCG/DAY PATCH, manufactured by Agile Therapeutics, Inc., is $66.9535 per EA (NDC 71671010003), effective Sep 30, 2026.
How has the price of TWIRLA 120-30 MCG/DAY PATCH changed over time?
Over the history we have for it, the NADAC for TWIRLA 120-30 MCG/DAY PATCH has risen 20.9%. It has been tracked across 250 weekly CMS publications since Dec 22, 2021.
What are the highest and lowest recorded NADAC prices for TWIRLA 120-30 MCG/DAY PATCH?
Since Dec 22, 2021, the NADAC for TWIRLA 120-30 MCG/DAY PATCH has ranged from a low of $55.4013 (Dec 22, 2021) to a high of $67.2133 (May 13, 2026), with a median of $65.2555 per EA.
Are there cheaper alternatives to TWIRLA 120-30 MCG/DAY PATCH?
No other NADAC-published product currently shares the active ingredient and strength of TWIRLA 120-30 MCG/DAY PATCH in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures TWIRLA 120-30 MCG/DAY PATCH?
TWIRLA 120-30 MCG/DAY PATCH (NDC 71671010003) is labeled by Agile Therapeutics, Inc., and CMS classifies it as a brand product.